Responsibility in Drug Advertising Act of 2024

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [S. 4785 Introduced in Senate (IS)] <DOC> 118th CONGRESS 2d Session S. 4785 To amend the Federal Food, Drug, and Cosmetic Act to restrict direct- to-consumer drug advertising. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES July 25, 2024 Mr. King (for himself, Mr. Welch, and Mr. Kaine) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to restrict direct- to-consumer drug advertising. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Responsibility in Drug Advertising Act of 2024''. SEC. 2. DIRECT-TO-CONSUMER DRUG ADVERTISING. The Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) is amended-- (1) in section 301 (21 U.S.C. 331), by adding at the end the following: ``(jjj) The conduct of direct-to-consumer advertisi…